University Medical Center Groningen
Clinical trials sponsored by University Medical Center Groningen, explained in plain language.
-
Immunotherapy before surgery shows promise for aggressive uterine cancer
Disease control OngoingThis study tests whether giving the immunotherapy drug pembrolizumab before standard hysterectomy can shrink tumors in people with a specific type of uterine cancer (MMRd). Twelve participants will receive 9 cycles of pembrolizumab before their surgery. The main goal is to see ho…
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for kidney patients: finerenone aims to slow disease damage
Disease control ENROLLING_BY_INVITATIONThis study tests whether the drug finerenone can lower protein in the urine (a sign of kidney damage) better than a placebo in 180 adults with chronic kidney disease who are not taking certain blood pressure medicines. Participants will take finerenone or a dummy pill for 6 month…
Phase: PHASE3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New combo therapy aims to boost survival in aggressive rectal cancer
Disease control OngoingThis study compares two treatment approaches for people with high-risk rectal cancer. The experimental group gets a short course of radiation (5 days) followed by several weeks of chemotherapy before surgery, while the standard group gets the usual longer radiation with chemo. Th…
Phase: PHASE3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Could a diabetes pill save lives in severe kidney disease? major trial underway.
Disease control ENROLLING_BY_INVITATIONThis study tests whether dapagliflozin, a drug originally for diabetes, can reduce the risk of death, kidney failure, and heart failure hospitalizations in 1,750 people with severe chronic kidney disease, including those on dialysis or with a kidney transplant. Participants will …
Phase: PHASE3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Brain scans reveal why some shed pounds after surgery while others Don't
Knowledge-focused OngoingThis study looks at why some people lose more weight than others after bariatric surgery. Researchers will use brain scans (PET) to measure changes in the brain's reward system, specifically dopamine receptors, in 30 adults who had surgery 2-3 years ago. The goal is to understand…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 17, 2026 00:53 UTC
-
New imaging technique could predict who benefits from CAR T-Cell therapy
Knowledge-focused OngoingThis study tests a new type of PET scan that looks for a protein called PD-L1 in people with large B-cell lymphoma receiving CAR T-cell therapy. The goal is to see if this scan can predict whether the treatment will work and help tell the difference between active cancer and infl…
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 17, 2026 00:53 UTC
-
Stem cells unlock mystery of chemo heart damage
Knowledge-focused OngoingThis study aims to find out why certain cancer drugs cause serious heart or lung side effects in some patients. Researchers will take skin or blood cells from 20 people who had extreme reactions to chemotherapy and turn them into stem cells to study the heart damage in a lab. The…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 17, 2026 00:50 UTC
-
Could testicular cancer treatment harm your heart? new study investigates
Knowledge-focused OngoingThis study looks at why testicular cancer survivors may have a higher risk of heart disease. Researchers will study nearly 1,000 men who had testicular cancer between 1976 and 2007, focusing on how their cancer treatment (like chemotherapy) might affect their heart health over ti…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 11, 2026 20:46 UTC
-
Scientists peek inside the gut to understand how immunotherapy works
Knowledge-focused OngoingThis study looks at how the immune system in the gut changes when people with cancer receive immunotherapy. Researchers will take small tissue samples from the gut and blood samples before and during treatment. The goal is to learn more about the body's response, not to test a ne…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC